Peptide Encyclopedia / Adamax
EncyclopediaAdamax is a synthetic ACTH(4-10)-derived peptide, an N-acetyl amidated cousin of Semax pitched for nootropic and neuroprotective effects. Little of the data is specific to Adamax, most gets extrapolated from Semax research, and it stays unapproved and gray-market in the US. Educational, not medical advice.
| Category | Cognitive |
| Regulatory status | Not FDA-approved; research chemical only. |
A synthetic ACTH(4-10)-derived peptide closely related to Semax (an N-acetyl, amidated analog), proposed to modulate BDNF and neurotrophic signaling for nootropic/neuroprotective effects. Mechanism is proposed rather than firmly established.
uncertain; the amidation/acetylation is intended to increase stability versus Semax, but no rigorous human PK exists. Commonly reported use/dosing: No validated protocol. Marketed as a research chemical; reported intranasal/subcutaneous microgram dosing is anecdotal and not clinically established.
Not FDA-approved; research chemical only. Semax itself is approved/used only in Russia and some neighboring countries, not the US. Adamax is unapproved and gray-market.
Little to no human safety data for this specific analog; unknown long-term effects and research-grade purity concerns. Experimental use only.
Minimal published data specific to Adamax; extrapolated from Semax-family research. Not clinically validated.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. Adamax may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.
